glp-1 agonsit agonists approved for clinical use. GLP-1 agonists are available How GLP-1 Receptor Agonists Evolved

Both drugs are given as a once-weekly subcutaneous injection

for obesity, 17% require a behavior change program as a prerequisite for coverage 94% of all respondents believe utilization will increase over the next three years Navigating GLP-1, Diabetes and Obesity Costs Without getting into efficacy of individual drugs, as a class they improve glycemic control for patients with T2D and reduce body mass index (BMI) between 7% and 16% in a year (+/- a few months)

Liraglutide is an injectable drug taken once a day, while semaglutide is an injectable drug taken once a week or an oral drug taken daily

"We think that some of these people may be changing behavior, nutrition, lifestyle, [and] also may be changing the hormones in their body by being on [GLP-1 medications], changing how their brain sort of operates or functions permanently," Narula said